OREX - Orexigen Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Orexigen Therapeutics's activity chart (see below) currently has 5 price targets and 5 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 16.67% with an average time for these price targets to be met of 28 days.

Most recent stock forecast was given by from on 16-Mar-2016. First documented stock forecast 07-Aug-2014.

Best performing analysts who are covering OREX - Orexigen Therapeutics:

Charles Duncan Simos Simeonidis Paul Matteis Steve Byrne

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 16-Mar-2016

$6

$5.78 (2627.27%)

$140

10 years 6 months 5 days ago
(16-Mar-2016)

1/2 (50%)

$0.7 (13.21%)

84

Hold Since 16-Mar-2016

10 years 6 months 5 days ago
(16-Mar-2016)

0/2 (0%)

$88 (400.00%)

Buy Since 26-Mar-2015

$20

$19.78 (8990.91%)

$110

10 years 6 months 29 days ago
(23-Feb-2016)

0/3 (0%)

$4.3 (27.39%)

Sell Since 11-Dec-2015

10 years 9 months 10 days ago
(11-Dec-2015)

0/1 (0%)

$47.9 (91.94%)

Show more analysts

Please expand the browser size to see the chart

What is OREX (Orexigen Therapeutics) average time for price targets to be met?

On average it took 28 days for the stock forecasts to be reached, with an average price target met ratio of 16.67%.

Which analyst most recently updated their price target on OREX (Orexigen Therapeutics)?

Which analyst has the most public recommendations on OREX (Orexigen Therapeutics)?

has 0 price targets and 0 ratings on OREX

Which analyst is the currently most bullish on OREX (Orexigen Therapeutics)?

Paul Matteis with the highest potential upside of $19.78

Which analyst is the currently most reserved on OREX (Orexigen Therapeutics)?

Charles Duncan with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?